{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T01:54:10Z","timestamp":1782698050422,"version":"3.54.5"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"CSUSB Office of Research"},{"name":"California State University CSUPERB New Investigator Grant program"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bmcl.2020.127683","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T16:31:24Z","timestamp":1605889884000},"page":"127683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin"],"prefix":"10.1016","volume":"32","author":[{"given":"Gulbag","family":"Kahlon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio","family":"Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Masvlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmett","family":"Pompa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimrat","family":"Brar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Eagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc O.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armann","family":"Andaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff P.","family":"Chance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Fejzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Keniston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nohemy","family":"Celis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Trieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy P.","family":"Mallari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2020.127683_b0005","unstructured":"World Health Organization. World Malaria Report 2019. https:\/\/apps.who.int\/iris\/rest\/bitstreams\/1262394\/retrieve (accessed 7\/22\/2020)."},{"key":"10.1016\/j.bmcl.2020.127683_b0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2958.2006.05443.x","article-title":"A role for falcilysin in transit peptide degradation in the Plasmodium falciparum apicoplast","volume":"63","author":"Ponpuak","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bmcl.2020.127683_b0015","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.1074\/jbc.M306842200","article-title":"Plasmodium falciparum falcilysin: a metalloprotease with dual specificity","volume":"278","author":"Murata","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2020.127683_b0020","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.bmcl.2018.04.010","article-title":"Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial protease","volume":"28","author":"Chance","year":"2018","journal-title":"Bioorg Med Chemistry Lett"},{"key":"10.1016\/j.bmcl.2020.127683_b0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1021\/jm990366q","article-title":"Design and synthesis of piperazine-based matrix metalloproteinase inhibitors","volume":"43","author":"Cheng","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127683_b0030","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1021\/ci300604z","article-title":"Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise","volume":"53","author":"Koes","year":"2013","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2020.127683_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107532","article-title":"Evaluation of consensus scoring methods for AutoDock Vina, smina and idock","volume":"96","author":"Masters","year":"2020","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.bmcl.2020.127683_b0040","unstructured":"Case DA, Ben-Shalom IY, Brozell SR, et al., AMBER 2018, University of California, San Francisco."},{"key":"10.1016\/j.bmcl.2020.127683_b0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Exp Opin Drug Discov"},{"key":"10.1016\/j.bmcl.2020.127683_b0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA Methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2020.127683_b0055","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jcc.21666","article-title":"Assessing the performance of the molecular mechanics\/poisson boltzmann surface area and molecular mechanics\/generalized born surface area methods. II. The accuracy of ranking poses generated from docking","volume":"32","author":"Hou","year":"2011","journal-title":"J Comput Chem"}],"updated-by":[{"DOI":"10.1016\/j.bmcl.2021.127836","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000}}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20307940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20307940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:38:11Z","timestamp":1760773091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X20307940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":11,"alternative-id":["S0960894X20307940"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127683","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bmcl.2021.127836","asserted-by":"object"}]},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127683"}}